Portfolio Holdings Detail for ISIN IE00BMXC7V63
Stock Name / Fund iShares S&P 500 Paris-Aligned Climate UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker UPABz(USD) CXE
ETF Ticker UQAB.DE(EUR) CXE
ETF Ticker UPAB(USD) Euronext Amsterdam

Holdings detail for LLY

Stock Name	Eli Lilly and Company
Ticker	LLY(EUR) F
TYPE	Common Stock
Country	Germany
ISIN	US5324571083
LEI	FRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG: Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs: With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About: Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price: Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial: (RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY: The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today: Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock: Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years: Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever: Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years: Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?: Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!: My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks: In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?: Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies: Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats: Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble: Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years: Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade: Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way: Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly: In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis: Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.: Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now: Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks: Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?: Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy: In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares S&P 500 Paris-Aligned Climate UCITS ETF USD (Acc) LLY holdings

Date	Number of LLY Shares Held	Base Market Value of LLY Shares	Local Market Value of LLY Shares	Change in LLY Shares Held	Change in LLY Base Value	Current Price per LLY Share Held	Previous Price per LLY Share Held
2025-12-04 (Thursday)	4,669	USD 4,736,654	USD 4,736,654
2025-12-03 (Wednesday)	4,669	USD 4,825,692	USD 4,825,692	0	USD -58,642	USD 1033.56	USD 1046.12
2025-12-02 (Tuesday)	4,669	USD 4,884,334	USD 4,884,334	-102	USD -162,859	USD 1046.12	USD 1057.89
2025-12-01 (Monday)	4,771	USD 5,047,193	USD 5,047,193	0	USD -83,874	USD 1057.89	USD 1075.47
2025-11-28 (Friday)	4,771	USD 5,131,067	USD 5,131,067	-34	USD -202,195	USD 1075.47	USD 1109.94
2025-11-25 (Tuesday)	4,805	USD 5,333,262	USD 5,333,262	34	USD 227,529	USD 1109.94	USD 1070.16
2025-11-24 (Monday)	4,771	USD 5,105,733	USD 5,105,733	0	USD 49,904	USD 1070.16	USD 1059.7
2025-11-21 (Friday)	4,771	USD 5,055,829	USD 5,055,829	0	USD 78,292	USD 1059.7	USD 1043.29
2025-11-20 (Thursday)	4,771	USD 4,977,537	USD 4,977,537	-17	USD 45,658	USD 1043.29	USD 1030.05
2025-11-18 (Tuesday)	4,788	USD 4,931,879	USD 4,931,879	0	USD 39,979	USD 1030.05	USD 1021.7
2025-11-17 (Monday)	4,788	USD 4,891,900	USD 4,891,900	-136	USD -156,579	USD 1021.7	USD 1025.28

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE00BMXC7V63

Show aggregate share trades of LLY

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 SELL -102 1,068.180 1,040.360 1,043.142 EUR -106,400 816.99 Loss of -23,068 on sale
2025-11-28 SELL -34 1,098.870 1,067.800 1,070.907 EUR -36,411 814.68 Loss of -8,712 on sale
2025-11-25 BUY 34 1,111.110 1,073.250 1,077.036 EUR 36,619 813.30
2025-11-20 SELL -17 1,057.000 1,038.250 1,040.125 EUR -17,682 809.84 Loss of -3,915 on sale
2025-11-17 SELL -136 1,032.141 998.302 1,001.685 EUR -136,229 807.79 Loss of -26,370 on sale
2025-11-03 SELL -425 901.339 862.680 866.546 EUR -368,282 801.22 Loss of -27,762 on sale
2025-10-31 BUY 17 869.910 834.950 838.446 EUR 14,254 800.92
2025-10-23 SELL -68 821.040 824.700 824.334 EUR -56,055 800.17 Loss of -1,643 on sale
2025-10-22 SELL -34 812.430 815.940 815.589 EUR -27,730 800.10 Loss of -527 on sale
2025-10-01 SELL -17 825.420 833.300 832.512 EUR -14,153 799.16 Loss of -567 on sale
2025-09-29 SELL -289 726.510 727.860 727.725 EUR -210,313 799.76 Profit of 20,817 on sale
2025-09-18 BUY 16 762.930 772.540 771.579 EUR 12,345 800.86
2025-09-10 SELL -32 754.620 755.800 755.682 EUR -24,182 801.90 Profit of 1,479 on sale
2025-08-20 BUY 80 705.440 705.800 705.764 EUR 56,461 804.14
2025-08-15 SELL -32 701.230 706.790 706.234 EUR -22,599 806.00 Profit of 3,193 on sale
2025-07-15 SELL -112 771.750 805.420 802.053 EUR -89,830 807.50 Profit of 610 on sale
2025-07-11 SELL -144 793.010 795.730 795.458 EUR -114,546 807.65 Profit of 1,756 on sale
2025-07-09 SELL -32 786.920 794.000 793.292 EUR -25,385 807.90 Profit of 467 on sale
2025-07-03 SELL -32 780.670 783.550 783.262 EUR -25,064 808.71 Profit of 814 on sale
2025-07-02 SELL -160 779.280 779.840 779.784 EUR -124,765 808.91 Profit of 4,660 on sale
2025-06-30 SELL -464 779.530 785.000 784.453 EUR -363,986 809.11 Profit of 11,441 on sale
2025-06-20 SELL -5,228 762.730 786.000 783.673 EUR -4,097,042 810.40 Profit of 139,717 on sale
2025-06-13 SELL -232 819.360 825.000 824.436 EUR -191,269 810.87 Loss of -3,147 on sale
2025-06-12 SELL -174 812.030 818.560 817.907 EUR -142,316 810.86 Loss of -1,226 on sale
2025-06-11 SELL -522 808.610 820.720 819.509 EUR -427,784 810.88 Loss of -4,505 on sale
2025-06-10 SELL -638 807.190 808.630 808.486 EUR -515,814 810.91 Profit of 1,544 on sale
2025-06-05 BUY 174 765.680 770.000 769.568 EUR 133,905 811.86
2025-05-19 SELL -29 755.110 758.720 758.359 EUR -21,992 820.62 Profit of 1,806 on sale
2025-05-13 BUY 87 746.060 759.500 758.156 EUR 65,960 823.57
2025-05-02 BUY 116 823.620 831.530 830.739 EUR 96,366 826.68
2025-05-01 SELL -145 794.100 850.930 845.247 EUR -122,561 826.99 Loss of -2,647 on sale
2025-04-28 SELL -493 877.290 882.250 881.754 EUR -434,705 825.21 Loss of -27,879 on sale
2025-04-16 BUY 116 734.900 756.300 754.160 EUR 87,483 824.86
2025-04-08 BUY 174 726.240 763.500 759.774 EUR 132,201 830.65
2025-04-07 SELL -464 723.730 748.000 745.573 EUR -345,946 831.90 Profit of 40,054 on sale
2025-04-04 SELL -87 738.210 768.270 765.264 EUR -66,578 833.00 Profit of 5,893 on sale
2025-03-28 SELL -1,450 822.510 829.780 829.053 EUR -1,202,127 833.74 Profit of 6,798 on sale
2025-03-27 SELL -58 821.670 826.770 826.260 EUR -47,923 833.89 Profit of 443 on sale
2025-03-24 SELL -58 864.900 866.870 866.673 EUR -50,267 833.34 Loss of -1,933 on sale
2025-03-21 BUY 146 837.570 850.430 849.144 EUR 123,975 833.29
2025-03-18 SELL -696 822.510 836.290 834.912 EUR -581,099 833.26 Loss of -1,153 on sale
2025-03-14 SELL -192 813.480 815.210 815.037 EUR -156,487 833.65 Profit of 3,575 on sale
2025-03-13 SELL -29 801.650 821.110 819.164 EUR -23,756 834.11 Profit of 433 on sale
2025-03-12 BUY 290 821.860 834.650 833.371 EUR 241,678 834.29
2025-03-11 BUY 377 824.060 832.350 831.521 EUR 313,483 834.44
2025-03-07 BUY 174 869.580 908.000 904.158 EUR 157,323 833.98
2025-03-05 BUY 377 929.720 930.490 930.413 EUR 350,766 832.50
2025-02-26 BUY 58 915.010 922.430 921.688 EUR 53,458 825.52
2025-02-12 BUY 58 872.970 877.780 877.299 EUR 50,883 816.87
2025-02-05 BUY 116 842.180 846.900 846.428 EUR 98,186 811.53
2025-01-02 BUY 153 778.070 787.000 786.107 EUR 120,274 814.31
2024-12-09 SELL -30 803.580 823.700 821.688 EUR -24,651 815.08 Loss of -198 on sale
2024-12-03 SELL -60 813.330 817.130 816.750 EUR -49,005 813.87 Loss of -173 on sale
2024-12-02 BUY 30 799.800 805.350 804.795 EUR 24,144 814.37
2024-11-29 BUY 60 795.350 800.330 799.832 EUR 47,990 815.07
2024-11-27 BUY 150 788.190 794.830 794.166 EUR 119,125 817.22
2024-11-26 BUY 180 789.320 807.000 805.232 EUR 144,942 819.65
2024-11-26 BUY 180 789.320 807.000 805.232 EUR 144,942 819.65
2024-11-22 BUY 60 748.010 761.280 759.953 EUR 45,597 829.70
2024-11-19 BUY 60 729.730 730.000 729.973 EUR 43,798 844.76
2024-11-18 BUY 90 727.200 734.000 733.320 EUR 65,999 852.10
2024-11-12 BUY 30 818.860 833.990 832.477 EUR 24,974 854.32
2024-11-05 BUY 300 806.060 809.210 808.895 EUR 242,669 873.03
2024-10-31 BUY 120 829.740 853.500 851.124 EUR 102,135 893.57
2024-10-30 BUY 450 846.830 860.500 859.133 EUR 386,610 900.25
2024-10-21 BUY 60 906.130 918.860 917.587 EUR 55,055 0.00
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	SELL	-102	1,068.180	1,040.360	1,043.142	EUR -106,400	816.99 Loss of -23,068 on sale
2025-11-28	SELL	-34	1,098.870	1,067.800	1,070.907	EUR -36,411	814.68 Loss of -8,712 on sale
2025-11-25	BUY	34	1,111.110	1,073.250	1,077.036	EUR 36,619	813.30
2025-11-20	SELL	-17	1,057.000	1,038.250	1,040.125	EUR -17,682	809.84 Loss of -3,915 on sale
2025-11-17	SELL	-136	1,032.141	998.302	1,001.685	EUR -136,229	807.79 Loss of -26,370 on sale
2025-11-03	SELL	-425	901.339	862.680	866.546	EUR -368,282	801.22 Loss of -27,762 on sale
2025-10-31	BUY	17	869.910	834.950	838.446	EUR 14,254	800.92
2025-10-23	SELL	-68	821.040	824.700	824.334	EUR -56,055	800.17 Loss of -1,643 on sale
2025-10-22	SELL	-34	812.430	815.940	815.589	EUR -27,730	800.10 Loss of -527 on sale
2025-10-01	SELL	-17	825.420	833.300	832.512	EUR -14,153	799.16 Loss of -567 on sale
2025-09-29	SELL	-289	726.510	727.860	727.725	EUR -210,313	799.76 Profit of 20,817 on sale
2025-09-18	BUY	16	762.930	772.540	771.579	EUR 12,345	800.86
2025-09-10	SELL	-32	754.620	755.800	755.682	EUR -24,182	801.90 Profit of 1,479 on sale
2025-08-20	BUY	80	705.440	705.800	705.764	EUR 56,461	804.14
2025-08-15	SELL	-32	701.230	706.790	706.234	EUR -22,599	806.00 Profit of 3,193 on sale
2025-07-15	SELL	-112	771.750	805.420	802.053	EUR -89,830	807.50 Profit of 610 on sale
2025-07-11	SELL	-144	793.010	795.730	795.458	EUR -114,546	807.65 Profit of 1,756 on sale
2025-07-09	SELL	-32	786.920	794.000	793.292	EUR -25,385	807.90 Profit of 467 on sale
2025-07-03	SELL	-32	780.670	783.550	783.262	EUR -25,064	808.71 Profit of 814 on sale
2025-07-02	SELL	-160	779.280	779.840	779.784	EUR -124,765	808.91 Profit of 4,660 on sale
2025-06-30	SELL	-464	779.530	785.000	784.453	EUR -363,986	809.11 Profit of 11,441 on sale
2025-06-20	SELL	-5,228	762.730	786.000	783.673	EUR -4,097,042	810.40 Profit of 139,717 on sale
2025-06-13	SELL	-232	819.360	825.000	824.436	EUR -191,269	810.87 Loss of -3,147 on sale
2025-06-12	SELL	-174	812.030	818.560	817.907	EUR -142,316	810.86 Loss of -1,226 on sale
2025-06-11	SELL	-522	808.610	820.720	819.509	EUR -427,784	810.88 Loss of -4,505 on sale
2025-06-10	SELL	-638	807.190	808.630	808.486	EUR -515,814	810.91 Profit of 1,544 on sale
2025-06-05	BUY	174	765.680	770.000	769.568	EUR 133,905	811.86
2025-05-19	SELL	-29	755.110	758.720	758.359	EUR -21,992	820.62 Profit of 1,806 on sale
2025-05-13	BUY	87	746.060	759.500	758.156	EUR 65,960	823.57
2025-05-02	BUY	116	823.620	831.530	830.739	EUR 96,366	826.68
2025-05-01	SELL	-145	794.100	850.930	845.247	EUR -122,561	826.99 Loss of -2,647 on sale
2025-04-28	SELL	-493	877.290	882.250	881.754	EUR -434,705	825.21 Loss of -27,879 on sale
2025-04-16	BUY	116	734.900	756.300	754.160	EUR 87,483	824.86
2025-04-08	BUY	174	726.240	763.500	759.774	EUR 132,201	830.65
2025-04-07	SELL	-464	723.730	748.000	745.573	EUR -345,946	831.90 Profit of 40,054 on sale
2025-04-04	SELL	-87	738.210	768.270	765.264	EUR -66,578	833.00 Profit of 5,893 on sale
2025-03-28	SELL	-1,450	822.510	829.780	829.053	EUR -1,202,127	833.74 Profit of 6,798 on sale
2025-03-27	SELL	-58	821.670	826.770	826.260	EUR -47,923	833.89 Profit of 443 on sale
2025-03-24	SELL	-58	864.900	866.870	866.673	EUR -50,267	833.34 Loss of -1,933 on sale
2025-03-21	BUY	146	837.570	850.430	849.144	EUR 123,975	833.29
2025-03-18	SELL	-696	822.510	836.290	834.912	EUR -581,099	833.26 Loss of -1,153 on sale
2025-03-14	SELL	-192	813.480	815.210	815.037	EUR -156,487	833.65 Profit of 3,575 on sale
2025-03-13	SELL	-29	801.650	821.110	819.164	EUR -23,756	834.11 Profit of 433 on sale
2025-03-12	BUY	290	821.860	834.650	833.371	EUR 241,678	834.29
2025-03-11	BUY	377	824.060	832.350	831.521	EUR 313,483	834.44
2025-03-07	BUY	174	869.580	908.000	904.158	EUR 157,323	833.98
2025-03-05	BUY	377	929.720	930.490	930.413	EUR 350,766	832.50
2025-02-26	BUY	58	915.010	922.430	921.688	EUR 53,458	825.52
2025-02-12	BUY	58	872.970	877.780	877.299	EUR 50,883	816.87
2025-02-05	BUY	116	842.180	846.900	846.428	EUR 98,186	811.53
2025-01-02	BUY	153	778.070	787.000	786.107	EUR 120,274	814.31
2024-12-09	SELL	-30	803.580	823.700	821.688	EUR -24,651	815.08 Loss of -198 on sale
2024-12-03	SELL	-60	813.330	817.130	816.750	EUR -49,005	813.87 Loss of -173 on sale
2024-12-02	BUY	30	799.800	805.350	804.795	EUR 24,144	814.37
2024-11-29	BUY	60	795.350	800.330	799.832	EUR 47,990	815.07
2024-11-27	BUY	150	788.190	794.830	794.166	EUR 119,125	817.22
2024-11-26	BUY	180	789.320	807.000	805.232	EUR 144,942	819.65
2024-11-26	BUY	180	789.320	807.000	805.232	EUR 144,942	819.65
2024-11-22	BUY	60	748.010	761.280	759.953	EUR 45,597	829.70
2024-11-19	BUY	60	729.730	730.000	729.973	EUR 43,798	844.76
2024-11-18	BUY	90	727.200	734.000	733.320	EUR 65,999	852.10
2024-11-12	BUY	30	818.860	833.990	832.477	EUR 24,974	854.32
2024-11-05	BUY	300	806.060	809.210	808.895	EUR 242,669	873.03
2024-10-31	BUY	120	829.740	853.500	851.124	EUR 102,135	893.57
2024-10-30	BUY	450	846.830	860.500	859.133	EUR 386,610	900.25
2024-10-21	BUY	60	906.130	918.860	917.587	EUR 55,055	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	432,038	935	1,319,853	32.7%
2025-09-18	547,818	126	1,290,147	42.5%
2025-09-17	437,337	427	1,166,204	37.5%
2025-09-16	532,698	1,829	1,463,374	36.4%
2025-09-15	424,979	701	1,071,487	39.7%
2025-09-12	267,121	172	826,802	32.3%
2025-09-11	249,803	1,484	850,461	29.4%
2025-09-10	415,442	1,025	989,008	42.0%
2025-09-09	559,805	667	1,270,800	44.1%
2025-09-08	856,018	4,682	1,937,447	44.2%
2025-09-05	679,276	1,050	1,405,239	48.3%
2025-09-04	337,491	53	982,751	34.3%
2025-09-03	214,691	496	766,157	28.0%
2025-09-02	430,477	2,977	1,131,908	38.0%
2025-08-29	357,538	602	889,509	40.2%
2025-08-28	433,687	1,099	1,113,568	38.9%
2025-08-27	860,715	6,009	1,681,353	51.2%
2025-08-26	1,548,460	12,105	2,955,348	52.4%
2025-08-25	566,454	3,586	1,323,249	42.8%
2025-08-22	749,615	1,957	1,460,713	51.3%
2025-08-21	651,639	223	1,570,067	41.5%
2025-08-20	679,554	2,698	1,870,241	36.3%
2025-08-19	787,909	935	2,788,740	28.3%
2025-08-18	756,143	1,095	1,727,603	43.8%
2025-08-15	1,814,721	836	3,422,260	53.0%
2025-08-14	1,852,940	5,382	3,602,829	51.4%
2025-08-13	1,254,225	3,473	2,774,100	45.2%
2025-08-12	990,110	3,190	2,845,896	34.8%
2025-08-11	1,290,063	1,615	5,196,302	24.8%
2025-08-08	2,448,706	300,870	6,239,830	39.2%
2025-08-07	4,197,951	489,618	10,364,294	40.5%
2025-08-06	440,144	1,120	1,811,262	24.3%
2025-08-05	331,460	921	993,178	33.4%
2025-08-04	474,905	1,408	1,273,995	37.3%
2025-08-01	530,569	7,139	1,882,098	28.2%
2025-07-31	882,506	3,670	2,110,030	41.8%
2025-07-30	745,614	392	1,827,435	40.8%
2025-07-29	1,081,849	571	2,607,245	41.5%
2025-07-28	304,841	7,460	1,004,032	30.4%
2025-07-25	365,417	265	1,055,273	34.6%
2025-07-24	321,799	762	1,167,147	27.6%
2025-07-23	485,719	3,471	1,044,919	46.5%
2025-07-22	241,098	3,036	874,717	27.6%
2025-07-21	418,014	854	1,180,445	35.4%
2025-07-18	623,498	651	1,225,333	50.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares S&P 500 Paris-Aligned Climate UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	UPABz(USD) CXE
ETF Ticker	UQAB.DE(EUR) CXE
ETF Ticker	UPAB(USD) Euronext Amsterdam